Management and toxicological analysis of ocular hypertension after EyeCee® ONE intraocular lens implantation: a case series

The EyeCee® ONE intraocular lens (Nidek, Gamagori, Japan) has been withdrawn from the market due to a high number of reports of severe ocular hypertension (OHT) following phacoemulsification with implantation of …

This post was originally published on this site